ES2083871T3 - Composicion para la aplicacion topica. - Google Patents

Composicion para la aplicacion topica.

Info

Publication number
ES2083871T3
ES2083871T3 ES93912637T ES93912637T ES2083871T3 ES 2083871 T3 ES2083871 T3 ES 2083871T3 ES 93912637 T ES93912637 T ES 93912637T ES 93912637 T ES93912637 T ES 93912637T ES 2083871 T3 ES2083871 T3 ES 2083871T3
Authority
ES
Spain
Prior art keywords
composition
melanine
added
topical use
light protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93912637T
Other languages
English (en)
Inventor
Udo Gross
Leonhard Zastrow
Joachim Roding
Klaus Stanzl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lancaster Group AG
Original Assignee
Lancaster Group AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lancaster Group AG filed Critical Lancaster Group AG
Application granted granted Critical
Publication of ES2083871T3 publication Critical patent/ES2083871T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA INVENCION SE REFIERE A UNA COMPOSICION PARA UTILIZACION TOPICA CON PROPIEDADES DE PROTECCION DE LUZ EN UNA FORMA DE APLICACION ESPECIAL. EL PROBLEMA CON LOS AGENTES DE PROTECCION DE LUZ CONOCIDOS CONTENIENDO MELANINA ACTIVA COMO SUSTANCIA ACTIVA ES UN TRANSPORTE DE MELANINA INSUFICIENTE AL LUGAR DE ACTIVIDAD. LA INVENCION RESUELVE EL PROBLEMA CON UNA COMPOSICION DE UTILIZACION TOPICA CARACTERIZADA POR UN CONTENIDO EN MELANINA DISUELTO O DISPERSO EN UNO O VARIOS FLUORCARBONOS DISPONIBLES COMO AGREGADOS FOSFOLIPIDOS LAMINADOS DE FORMA ASIMETRICA EN UN SISTEMA ACUOSO, CONJUNTAMENTE CON UN FOSFOLIPIDO. EL TAMAÑO DE PARTICULA DEL AGREGADO SE ENCUENTRA EN LA ZONA DESDE 200 A 3.000 NM.
ES93912637T 1992-06-26 1993-06-24 Composicion para la aplicacion topica. Expired - Lifetime ES2083871T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221269A DE4221269C1 (de) 1992-06-26 1992-06-26 Zubereitung zur topischen Anwendung

Publications (1)

Publication Number Publication Date
ES2083871T3 true ES2083871T3 (es) 1996-04-16

Family

ID=6462056

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93912637T Expired - Lifetime ES2083871T3 (es) 1992-06-26 1993-06-24 Composicion para la aplicacion topica.

Country Status (20)

Country Link
EP (1) EP0647129B1 (es)
JP (1) JP3599113B2 (es)
AT (1) ATE131031T1 (es)
AU (1) AU671645B2 (es)
CA (1) CA2138975C (es)
CZ (1) CZ283659B6 (es)
DE (2) DE4221269C1 (es)
DK (1) DK0647129T3 (es)
ES (1) ES2083871T3 (es)
FI (1) FI946057A0 (es)
GR (1) GR3018337T3 (es)
HK (1) HK1002701A1 (es)
HU (1) HUT68858A (es)
IL (1) IL105947A (es)
NO (1) NO303666B1 (es)
NZ (1) NZ253000A (es)
PL (1) PL172360B1 (es)
SK (1) SK279823B6 (es)
WO (1) WO1994000097A1 (es)
ZA (1) ZA934573B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643554A (en) * 1993-04-30 1997-07-01 Dusa Pharmaceuticals, Inc. Lipomelanim composition
DE4443243C2 (de) * 1994-11-24 1998-02-19 Lancaster Group Gmbh Sonnenschutzzubereitung mit erhöhtem Lichtschutzfaktor
US6303106B1 (en) * 1995-12-07 2001-10-16 Zylepsis Limited Allomelanin production
RU2143263C1 (ru) * 1998-08-06 1999-12-27 Махлис Леонид Абрамович Эмульсия перфторуглеродов для косметических и/или дерматологических препаратов
US6321335B1 (en) 1998-10-30 2001-11-20 Acqis Technology, Inc. Password protected modular computer method and device
US6311268B1 (en) 1998-11-06 2001-10-30 Acqis Technology, Inc. Computer module device and method for television use
US6643777B1 (en) 1999-05-14 2003-11-04 Acquis Technology, Inc. Data security method and device for computer modules
US6718415B1 (en) 1999-05-14 2004-04-06 Acqis Technology, Inc. Computer system and method including console housing multiple computer modules having independent processing units, mass storage devices, and graphics controllers
US7990724B2 (en) 2006-12-19 2011-08-02 Juhasz Paul R Mobile motherboard
RU2381792C2 (ru) * 2008-04-02 2010-02-20 Закрытое акционерное общество "Лаборатория Низар-А" Средство для мезотерапии

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0417104A4 (en) * 1988-03-11 1991-10-30 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
AU5195090A (en) * 1989-03-07 1990-10-09 Plough Inc. Liposome compositions
WO1991000110A1 (en) * 1989-07-05 1991-01-10 Alliance Pharmaceutical Corp. Fluorocarbon emulsions having saturated phospholipid emulsifiers
DE4127442C2 (de) * 1991-08-17 1996-08-22 Udo Dr Gros Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
HU9403736D0 (en) 1995-02-28
DE4221269C1 (de) 1993-12-09
WO1994000097A1 (de) 1994-01-06
NO303666B1 (no) 1998-08-17
PL172360B1 (en) 1997-09-30
JPH07508007A (ja) 1995-09-07
SK156694A3 (en) 1995-07-11
CZ283659B6 (cs) 1998-05-13
IL105947A0 (en) 1993-10-20
DE59301120D1 (de) 1996-01-18
EP0647129B1 (de) 1995-12-06
NO944956L (no) 1994-12-21
CZ326894A3 (en) 1995-09-13
FI946057A7 (fi) 1994-12-23
AU671645B2 (en) 1996-09-05
GR3018337T3 (en) 1996-03-31
AU4307993A (en) 1994-01-24
EP0647129A1 (de) 1995-04-12
IL105947A (en) 1997-07-13
FI946057L (fi) 1994-12-23
HK1002701A1 (en) 1998-09-11
SK279823B6 (sk) 1999-04-13
ATE131031T1 (de) 1995-12-15
FI946057A0 (fi) 1994-12-23
NZ253000A (en) 1997-05-26
NO944956D0 (no) 1994-12-21
JP3599113B2 (ja) 2004-12-08
DK0647129T3 (da) 1996-01-08
HUT68858A (en) 1995-08-28
CA2138975C (en) 2003-05-13
ZA934573B (en) 1994-01-31
CA2138975A1 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
ES2104797T3 (es) Composiciones farmaceuticas con actividad antagonista de angiotensina-ii.
ES2180938T3 (es) Donadores de oxido nitrico capaces de reducir la toxicidad de los farmacos.
GT199700089A (es) Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido.
CO4560552A1 (es) Antagonistas de receptores de taquicininas no peptidicos
GT199700033A (es) Derivados de 6-fenilpiridil-2-amina.
AR002007A1 (es) UNA COMPOSICION TERAPEUTICA DE APLICACION TOPICA QUE CONTIENE UN ANTAGONISTA DE SUSTANCIA P Y UTILIZACION DE DICHO ANTAGONISTA PARA LAPREPARACIóN DE DICHA COMPOSICION PARA DISMINUIR Y/O ELIMINAR UN EFECTO SECUNDARIO IRRITANTE DE UN PRODUCTO CONTENIDO EN LA MISMA.
ES2097787T5 (es) Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon.
AR092919A2 (es) Composicion farmaceutica liquida
MA29851B1 (fr) Composes et compositions contenant de la diarylamine et utilisation en tant que modulateurs de recepteurs de c-kit
FR2710063B1 (fr) 3-Aryl-benzofurannones, utilisées en tant que stabilisants, compositions les contenant, et leur utilisation.
GT199600051A (es) Metanolsulfonato de (1s, 2s)-1- (4-hidroxifenil)-2-(4-hidroxi-4- fenilpiperidin-1-il)-1-propanol trihidrato.
MX9304015A (es) Antagonistas de oxitoxina.
AR012217A1 (es) Una composicion topica para mejorar la penetracion de compuestos farmaceuticos
CO4940476A1 (es) Composiciones para el tratamiento y la prevencion de las trombosis arteriales y utilizacion de uninhibidor del factor xa solo o en combinacion con un antiagregante plaquetario
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
ES2165723T3 (es) Composiciones farmaceuticas conteniendo mupirocina.
AR000509A1 (es) Utilización de un antagonist de sustancia p para la preparación de una composición farmacéutica paratratar algunas enfermedades de la piel de origen neurogeno
PE20011188A1 (es) El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos
AR007021A1 (es) Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos
GT198170557A (es) 9-amino-1-hidroxioctahidrobenzo (c) quinolinas y sus deriva-dos.
BR9908427A (pt) Composições farmacêuticas e uso das mesmas
ES8700049A1 (es) Un procedimiento para la preparacion de una composicion topica para reducir la secrecion de sebo
ES2124983T5 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
ES2080037T3 (es) Medicamento de uso topico con actividad cicatrizante.
MX9203739A (es) Complejo organico de oro aplicado topicamente.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 647129

Country of ref document: ES